The Evolution of Histotripsy

January 30, 2018 |

The team at the University of Michigan has pioneered the development of histotripsy - a new technique to achieve mechanical fractionation of tissue structure using short, high intensity ultrasound pulses.

Share this Post

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on October 11, 2023
X New Twitter Logo
© 2019-2023 HistoSonics®. All rights reserved.